Showing results (1041-1050 of 1,797) with videos related to
Sort By:
Pageof 180
Mabs|January 13, 2010
Production of therapeutic antibodies with controlled fucosylationNaoko Yamane-Ohnuki, Mitsuo SatohMabs|January 13, 2010
Dimers and multimers of monoclonal IgG1 exhibit higher in vitro binding affinities to Fcgamma receptorsYin Luo, Zhaojiang Lu, Stephen W Raso, et al.Mabs|January 13, 2010
Preclinical development of monoclonal antibodies: considerations for the use of non-human primatesKathryn Chapman, Nick Pullen, Lee Coney, et al.Mabs|January 13, 2010
Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemiaMay Kung Sutherland, Changpu Yu, Timothy S Lewis, et al.Mabs|January 13, 2010
Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41Donna L Montgomery, Ying-Jie Wang, Renee Hrin, et al.Mabs|January 14, 2010
Charge-based analysis of antibodies with engineered cysteines: from multiple peaks to a single main peakXiaoying Nancy Chen, Mary Nguyen, Fred Jacobson, et al.Mabs|January 14, 2010
Antibody-maytansinoid conjugates for the treatment of myelomaRobert J Lutz, Kathleen R WhitemanMabs|January 14, 2010
Guardians at the gate: patent protection for therapeutic monoclonal antibodies--part 1Kevin W McCabeMabs|January 14, 2010
Guardians at the gate: patent protection of therapeutic monoclonal antibodies through product life cycle management--Part 3Kevin W McCabe, Paul A CalvoMabs|January 14, 2010
Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeuticsStephen Thompson, John Dessi, Colin H SelfPageof 180